Capecitabine in Metastatic Breast and GI Cancers

NCT02595320 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Gastrointestinal Cancer

Interventions

DRUG: Capecitabine

Sponsor

Qamar Khan